Monoclonal antibody shows promising results for rare liver disease
A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver disease called primary sclerosing cholangitis. Researchers learned that an anti-inflammatory and ...
Dec 23, 2025
0
15
